Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

P, Halloran; T, Mathew; S, Tomlanovich; C, Groth; L, Hooftman; C, Barker

doi:10.1097/00007890-199701150-00008

Public

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

Shared by NobleBlocks on Jan 1, 1997 • 12:00 AM UTC

Authors:

Halloran P

Mathew T

Tomlanovich S

Abstract

Background The search for more effective and less toxic immunosuppressive agents to control transplant rejection has led to the extensive testing of mycophenolate mofetil (MMF) in clinical renal transplantation.Methods A pooled analysis of three phase III, randomized, double-blind, multicenter clini...

Discussions